Bicyclic amides

Details for Australian Patent Application No. 2003223510 (hide)

Owner Merck & Co., Inc.

Inventors Hagmann, William, K.; Shah, Shrenik, K.; Lin, Linus, S.; Castonguay, Laurie, A.

Agent Spruson & Ferguson

Pub. Number AU-B-2003223510

PCT Number PCT/US03/10740

PCT Pub. Number WO2003/086288

Priority 60/372,234 12.04.02 US

Filing date 8 April 2003

Wipo publication date 27 October 2003

Acceptance publication date 8 May 2008

International Classifications

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/343 (2006.01) - condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone

A61K 31/353 (2006.01)

A61K 31/36 (2006.01)

A61K 31/403 (2006.01) - condensed with carbocyclic rings, e.g. carbazole

A61K 31/4433 (2006.01)

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/10 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/06 (2006.01) Drugs for disorders of the nervous system

A61P 25/08 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 25/36 (2006.01) Drugs for disorders of the nervous system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07C 233/59 (2006.01) Carboxylic acid amides

C07D 209/88 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 307/84 Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

Event Publications

7 August 2003 Complete Application Filed

  Priority application(s): 60/372,234 12.04.02 US

4 December 2003 Application Open to Public Inspection

  Published as AU-B-2003223510

8 May 2008 Application Accepted

  Published as AU-B-2003223510

4 September 2008 Standard Patent Sealed

21 January 2010 Amendment Made

  The nature of the amendment is: Amend the patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

3 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003223511-METHOD AND APPARATUS FOR UNDERFILLING SEMICONDUCTOR DEVICES

2003223509-INTERMEDIATES USEFUL IN THE MANUFACTURE OF WELL TREATMENT FLUIDS AND METHODS OF PREPARING SAME